Table of Content

1 Report Overview
1.1 Oncology Injection Drug Definition
1.2 Market by Type
1.2.1 Global Oncology Injection Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Organs
1.2.3 Central Nervous System
1.2.4 Circulatory/Musculoskeletal System
1.2.5 Other
1.3 Market Segment by Application
1.3.1 Global Oncology Injection Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Lymphoma
1.3.3 Myeloma
1.3.4 Prostate Cancer
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Oncology Injection Drug Sales
2.1 Global Oncology Injection Drug Revenue Estimates and Forecasts 2018-2034
2.2 Global Oncology Injection Drug Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Oncology Injection Drug Revenue by Region
2.3.1 Global Oncology Injection Drug Revenue by Region (2018-2023)
2.3.2 Global Oncology Injection Drug Revenue by Region (2024-2034)
2.4 Global Oncology Injection Drug Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Oncology Injection Drug Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Oncology Injection Drug Sales Quantity by Region
2.6.1 Global Oncology Injection Drug Sales Quantity by Region (2018-2023)
2.6.2 Global Oncology Injection Drug Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Oncology Injection Drug Sales Quantity by Manufacturers
3.1.1 Global Oncology Injection Drug Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Oncology Injection Drug Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Oncology Injection Drug Sales in 2024
3.2 Global Oncology Injection Drug Revenue by Manufacturers
3.2.1 Global Oncology Injection Drug Revenue by Manufacturers (2018-2023)
3.2.2 Global Oncology Injection Drug Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Oncology Injection Drug Revenue in 2024
3.3 Global Oncology Injection Drug Sales Price by Manufacturers
3.4 Global Key Players of Oncology Injection Drug, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Oncology Injection Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Oncology Injection Drug, Product Offered and Application
3.8 Global Key Manufacturers of Oncology Injection Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Oncology Injection Drug Sales Quantity by Type
4.1.1 Global Oncology Injection Drug Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Oncology Injection Drug Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Oncology Injection Drug Sales Quantity Market Share by Type (2018-2034)
4.2 Global Oncology Injection Drug Revenue by Type
4.2.1 Global Oncology Injection Drug Historical Revenue by Type (2018-2023)
4.2.2 Global Oncology Injection Drug Forecasted Revenue by Type (2024-2034)
4.2.3 Global Oncology Injection Drug Revenue Market Share by Type (2018-2034)
4.3 Global Oncology Injection Drug Price by Type
4.3.1 Global Oncology Injection Drug Price by Type (2018-2023)
4.3.2 Global Oncology Injection Drug Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Oncology Injection Drug Sales Quantity by Application
5.1.1 Global Oncology Injection Drug Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Oncology Injection Drug Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Oncology Injection Drug Sales Quantity Market Share by Application (2018-2034)
5.2 Global Oncology Injection Drug Revenue by Application
5.2.1 Global Oncology Injection Drug Historical Revenue by Application (2018-2023)
5.2.2 Global Oncology Injection Drug Forecasted Revenue by Application (2024-2034)
5.2.3 Global Oncology Injection Drug Revenue Market Share by Application (2018-2034)
5.3 Global Oncology Injection Drug Price by Application
5.3.1 Global Oncology Injection Drug Price by Application (2018-2023)
5.3.2 Global Oncology Injection Drug Price Forecast by Application (2024-2034)
6 North America
6.1 North America Oncology Injection Drug Sales by Company
6.1.1 North America Oncology Injection Drug Revenue by Company (2018-2023)
6.1.2 North America Oncology Injection Drug Sales Quantity by Company (2018-2023)
6.2 North America Oncology Injection Drug Market Size by Type
6.2.1 North America Oncology Injection Drug Sales Quantity by Type (2018-2034)
6.2.2 North America Oncology Injection Drug Revenue by Type (2018-2034)
6.3 North America Oncology Injection Drug Market Size by Application
6.3.1 North America Oncology Injection Drug Sales Quantity by Application (2018-2034)
6.3.2 North America Oncology Injection Drug Revenue by Application (2018-2034)
6.4 North America Oncology Injection Drug Market Size by Country
6.4.1 North America Oncology Injection Drug Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Oncology Injection Drug Revenue by Country (2018-2034)
6.4.3 North America Oncology Injection Drug Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Oncology Injection Drug Sales by Company
7.1.1 Europe Oncology Injection Drug Sales Quantity by Company (2018-2023)
7.1.2 Europe Oncology Injection Drug Revenue by Company (2018-2023)
7.2 Europe Oncology Injection Drug Market Size by Type
7.2.1 Europe Oncology Injection Drug Sales Quantity by Type (2018-2034)
7.2.2 Europe Oncology Injection Drug Revenue by Type (2018-2034)
7.3 Europe Oncology Injection Drug Market Size by Application
7.3.1 Europe Oncology Injection Drug Sales Quantity by Application (2018-2034)
7.3.2 Europe Oncology Injection Drug Revenue by Application (2018-2034)
7.4 Europe Oncology Injection Drug Market Size by Country
7.4.1 Europe Oncology Injection Drug Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Oncology Injection Drug Revenue by Country (2018-2034)
7.4.3 Europe Oncology Injection Drug Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Oncology Injection Drug Sales by Company
8.1.1 China Oncology Injection Drug Sales Quantity by Company (2018-2023)
8.1.2 China Oncology Injection Drug Revenue by Company (2018-2023)
8.2 China Oncology Injection Drug Market Size by Type
8.2.1 China Oncology Injection Drug Sales Quantity by Type (2018-2034)
8.2.2 China Oncology Injection Drug Revenue by Type (2018-2034)
8.3 China Oncology Injection Drug Market Size by Application
8.3.1 China Oncology Injection Drug Sales Quantity by Application (2018-2034)
8.3.2 China Oncology Injection Drug Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Oncology Injection Drug Sales by Company
9.1.1 APAC Oncology Injection Drug Sales Quantity by Company (2018-2023)
9.1.2 APAC Oncology Injection Drug Revenue by Company (2018-2023)
9.2 APAC Oncology Injection Drug Market Size by Type
9.2.1 APAC Oncology Injection Drug Sales Quantity by Type (2018-2034)
9.2.2 APAC Oncology Injection Drug Revenue by Type (2018-2034)
9.3 APAC Oncology Injection Drug Market Size by Application
9.3.1 APAC Oncology Injection Drug Sales Quantity by Application (2018-2034)
9.3.2 APAC Oncology Injection Drug Revenue by Application (2018-2034)
9.4 APAC Oncology Injection Drug Market Size by Region
9.4.1 APAC Oncology Injection Drug Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Oncology Injection Drug Revenue by Region (2018-2034)
9.4.3 APAC Oncology Injection Drug Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Oncology Injection Drug Sales by Company
10.1.1 Middle East, Africa and Latin America Oncology Injection Drug Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Oncology Injection Drug Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Oncology Injection Drug Market Size by Type
10.2.1 Middle East, Africa and Latin America Oncology Injection Drug Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Oncology Injection Drug Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Oncology Injection Drug Market Size by Application
10.3.1 Middle East, Africa and Latin America Oncology Injection Drug Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Oncology Injection Drug Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Oncology Injection Drug Market Size by Country
10.4.1 Middle East, Africa and Latin America Oncology Injection Drug Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Oncology Injection Drug Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Oncology Injection Drug Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Taj Oncology
11.1.1 Taj Oncology Company Information
11.1.2 Taj Oncology Overview
11.1.3 Taj Oncology Oncology Injection Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Taj Oncology Oncology Injection Drug Products and Services
11.1.5 Taj Oncology Oncology Injection Drug SWOT Analysis
11.1.6 Taj Oncology Recent Developments
11.2 S.G. Biopharm
11.2.1 S.G. Biopharm Company Information
11.2.2 S.G. Biopharm Overview
11.2.3 S.G. Biopharm Oncology Injection Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 S.G. Biopharm Oncology Injection Drug Products and Services
11.2.5 S.G. Biopharm Oncology Injection Drug SWOT Analysis
11.2.6 S.G. Biopharm Recent Developments
11.3 AdvaCare
11.3.1 AdvaCare Company Information
11.3.2 AdvaCare Overview
11.3.3 AdvaCare Oncology Injection Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 AdvaCare Oncology Injection Drug Products and Services
11.3.5 AdvaCare Oncology Injection Drug SWOT Analysis
11.3.6 AdvaCare Recent Developments
11.4 Merrimack
11.4.1 Merrimack Company Information
11.4.2 Merrimack Overview
11.4.3 Merrimack Oncology Injection Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Merrimack Oncology Injection Drug Products and Services
11.4.5 Merrimack Oncology Injection Drug SWOT Analysis
11.4.6 Merrimack Recent Developments
11.5 Celgene
11.5.1 Celgene Company Information
11.5.2 Celgene Overview
11.5.3 Celgene Oncology Injection Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Celgene Oncology Injection Drug Products and Services
11.5.5 Celgene Oncology Injection Drug SWOT Analysis
11.5.6 Celgene Recent Developments
11.6 Allos Therapeutics
11.6.1 Allos Therapeutics Company Information
11.6.2 Allos Therapeutics Overview
11.6.3 Allos Therapeutics Oncology Injection Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Allos Therapeutics Oncology Injection Drug Products and Services
11.6.5 Allos Therapeutics Oncology Injection Drug SWOT Analysis
11.6.6 Allos Therapeutics Recent Developments
11.7 Ferring Pharmaceuticals
11.7.1 Ferring Pharmaceuticals Company Information
11.7.2 Ferring Pharmaceuticals Overview
11.7.3 Ferring Pharmaceuticals Oncology Injection Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Ferring Pharmaceuticals Oncology Injection Drug Products and Services
11.7.5 Ferring Pharmaceuticals Oncology Injection Drug SWOT Analysis
11.7.6 Ferring Pharmaceuticals Recent Developments
11.8 Genzyme
11.8.1 Genzyme Company Information
11.8.2 Genzyme Overview
11.8.3 Genzyme Oncology Injection Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Genzyme Oncology Injection Drug Products and Services
11.8.5 Genzyme Oncology Injection Drug SWOT Analysis
11.8.6 Genzyme Recent Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Company Information
11.9.2 Eli Lilly Overview
11.9.3 Eli Lilly Oncology Injection Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Eli Lilly Oncology Injection Drug Products and Services
11.9.5 Eli Lilly Oncology Injection Drug SWOT Analysis
11.9.6 Eli Lilly Recent Developments
11.10 Praecis Pharmaceuticals
11.10.1 Praecis Pharmaceuticals Company Information
11.10.2 Praecis Pharmaceuticals Overview
11.10.3 Praecis Pharmaceuticals Oncology Injection Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Praecis Pharmaceuticals Oncology Injection Drug Products and Services
11.10.5 Praecis Pharmaceuticals Oncology Injection Drug SWOT Analysis
11.10.6 Praecis Pharmaceuticals Recent Developments
11.11 Millennium Pharmaceuticals
11.11.1 Millennium Pharmaceuticals Company Information
11.11.2 Millennium Pharmaceuticals Overview
11.11.3 Millennium Pharmaceuticals Oncology Injection Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 Millennium Pharmaceuticals Oncology Injection Drug Products and Services
11.11.5 Millennium Pharmaceuticals Recent Developments
11.12 Debiopharm
11.12.1 Debiopharm Company Information
11.12.2 Debiopharm Overview
11.12.3 Debiopharm Oncology Injection Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.12.4 Debiopharm Oncology Injection Drug Products and Services
11.12.5 Debiopharm Recent Developments
11.13 Alza
11.13.1 Alza Company Information
11.13.2 Alza Overview
11.13.3 Alza Oncology Injection Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.13.4 Alza Oncology Injection Drug Products and Services
11.13.5 Alza Recent Developments
11.14 CordenPharma
11.14.1 CordenPharma Company Information
11.14.2 CordenPharma Overview
11.14.3 CordenPharma Oncology Injection Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.14.4 CordenPharma Oncology Injection Drug Products and Services
11.14.5 CordenPharma Recent Developments
11.15 Pharmascience
11.15.1 Pharmascience Company Information
11.15.2 Pharmascience Overview
11.15.3 Pharmascience Oncology Injection Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.15.4 Pharmascience Oncology Injection Drug Products and Services
11.15.5 Pharmascience Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Oncology Injection Drug Value Chain Analysis
12.2 Oncology Injection Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oncology Injection Drug Production Mode & Process
12.4 Oncology Injection Drug Sales and Marketing
12.4.1 Oncology Injection Drug Sales Channels
12.4.2 Oncology Injection Drug Distributors
12.5 Oncology Injection Drug Customers
13 Market Dynamics
13.1 Oncology Injection Drug Industry Trends
13.2 Oncology Injection Drug Market Drivers
13.3 Oncology Injection Drug Market Challenges
13.4 Oncology Injection Drug Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Oncology Injection Drug Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Organs
Table 3. Major Manufacturers of Central Nervous System
Table 4. Major Manufacturers of Circulatory/Musculoskeletal System
Table 5. Major Manufacturers of Other
Table 6. Global Oncology Injection Drug Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global Oncology Injection Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Oncology Injection Drug Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Oncology Injection Drug Revenue Market Share by Region (2018-2023)
Table 10. Global Oncology Injection Drug Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Oncology Injection Drug Revenue Market Share by Region (2024-2034)
Table 12. Global Oncology Injection Drug Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 13. Global Oncology Injection Drug Sales by Region (2018-2023) & (K Pcs)
Table 14. Global Oncology Injection Drug Sales Market Share by Region (2018-2023)
Table 15. Global Oncology Injection Drug Sales by Region (2024-2034) & (K Pcs)
Table 16. Global Oncology Injection Drug Sales Market Share by Region (2024-2034)
Table 17. Global Oncology Injection Drug Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 18. Global Oncology Injection Drug Sales Quantity Share by Manufacturers (2018-2023)
Table 19. Global Oncology Injection Drug Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Oncology Injection Drug Revenue Share by Manufacturers (2018-2023)
Table 21. Global Oncology Injection Drug Price by Manufacturers 2018-2023 (USD/Pcs)
Table 22. Global Key Players of Oncology Injection Drug, Industry Ranking, 2021 VS 2024
Table 23. Global Oncology Injection Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Oncology Injection Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Injection Drug as of 2024)
Table 25. Global Key Manufacturers of Oncology Injection Drug, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Oncology Injection Drug, Product Offered and Application
Table 27. Global Key Manufacturers of Oncology Injection Drug, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Oncology Injection Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 30. Global Oncology Injection Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 31. Global Oncology Injection Drug Sales Quantity Share by Type (2018-2023)
Table 32. Global Oncology Injection Drug Sales Quantity Share by Type (2024-2034)
Table 33. Global Oncology Injection Drug Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Oncology Injection Drug Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Oncology Injection Drug Revenue Share by Type (2018-2023)
Table 36. Global Oncology Injection Drug Revenue Share by Type (2024-2034)
Table 37. Oncology Injection Drug Price by Type (2018-2023) & (USD/Pcs)
Table 38. Global Oncology Injection Drug Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 39. Global Oncology Injection Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 40. Global Oncology Injection Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 41. Global Oncology Injection Drug Sales Quantity Share by Application (2018-2023)
Table 42. Global Oncology Injection Drug Sales Quantity Share by Application (2024-2034)
Table 43. Global Oncology Injection Drug Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Oncology Injection Drug Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Oncology Injection Drug Revenue Share by Application (2018-2023)
Table 46. Global Oncology Injection Drug Revenue Share by Application (2024-2034)
Table 47. Oncology Injection Drug Price by Application (2018-2023) & (USD/Pcs)
Table 48. Global Oncology Injection Drug Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 49. North America Oncology Injection Drug Revenue by Company (2018-2023) & (US$ Million)
Table 50. North America Oncology Injection Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 51. North America Oncology Injection Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 52. North America Oncology Injection Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 53. North America Oncology Injection Drug Revenue by Type (2018-2023) & (US$ Million)
Table 54. North America Oncology Injection Drug Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Oncology Injection Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 56. North America Oncology Injection Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 57. North America Oncology Injection Drug Revenue by Application (2018-2023) & (US$ Million)
Table 58. North America Oncology Injection Drug Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Oncology Injection Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 60. North America Oncology Injection Drug Revenue by Country (2018-2023) & (US$ Million)
Table 61. North America Oncology Injection Drug Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Oncology Injection Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 63. North America Oncology Injection Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 64. Europe Oncology Injection Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 65. Europe Oncology Injection Drug Revenue by Company (2018-2023) & (US$ Million)
Table 66. Europe Oncology Injection Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 67. Europe Oncology Injection Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 68. Europe Oncology Injection Drug Revenue by Type (2018-2023) & (US$ Million)
Table 69. Europe Oncology Injection Drug Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Oncology Injection Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 71. Europe Oncology Injection Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 72. Europe Oncology Injection Drug Revenue by Application (2018-2023) & (US$ Million)
Table 73. Europe Oncology Injection Drug Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Oncology Injection Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 75. Europe Oncology Injection Drug Revenue by Country (2018-2023) & (US$ Million)
Table 76. Europe Oncology Injection Drug Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Oncology Injection Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 78. Europe Oncology Injection Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 79. China Oncology Injection Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 80. China Oncology Injection Drug Revenue by Company (2018-2023) & (US$ Million)
Table 81. China Oncology Injection Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 82. China Oncology Injection Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 83. China Oncology Injection Drug Revenue by Type (2018-2023) & (US$ Million)
Table 84. China Oncology Injection Drug Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Oncology Injection Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 86. China Oncology Injection Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 87. China Oncology Injection Drug Revenue by Application (2018-2023) & (US$ Million)
Table 88. China Oncology Injection Drug Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Oncology Injection Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 90. APAC Oncology Injection Drug Revenue by Company (2018-2023) & (US$ Million)
Table 91. APAC Oncology Injection Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 92. APAC Oncology Injection Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 93. APAC Oncology Injection Drug Revenue by Type (2018-2023) & (US$ Million)
Table 94. APAC Oncology Injection Drug Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Oncology Injection Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 96. APAC Oncology Injection Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 97. APAC Oncology Injection Drug Revenue by Application (2018-2023) & (US$ Million)
Table 98. APAC Oncology Injection Drug Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Oncology Injection Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 100. APAC Oncology Injection Drug Revenue by Region (2018-2023) & (US$ Million)
Table 101. APAC Oncology Injection Drug Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Oncology Injection Drug Sales Quantity by Region (2018-2023) & (K Pcs)
Table 103. APAC Oncology Injection Drug Sales Quantity by Region (2024-2034) & (K Pcs)
Table 104. Middle East, Africa and Latin America Oncology Injection Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 105. Middle East, Africa and Latin America Oncology Injection Drug Revenue by Company (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Oncology Injection Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 107. Middle East, Africa and Latin America Oncology Injection Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 108. Middle East, Africa and Latin America Oncology Injection Drug Revenue by Type (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Oncology Injection Drug Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Oncology Injection Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 111. Middle East, Africa and Latin America Oncology Injection Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 112. Middle East, Africa and Latin America Oncology Injection Drug Revenue by Application (2018-2023) & (US$ Million)
Table 113. Middle East, Africa and Latin America Oncology Injection Drug Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Oncology Injection Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Oncology Injection Drug Revenue by Country (2018-2023) & (US$ Million)
Table 116. Middle East, Africa and Latin America Oncology Injection Drug Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Oncology Injection Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 118. Middle East, Africa and Latin America Oncology Injection Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 119. Taj Oncology Company Information
Table 120. Taj Oncology Description and Overview
Table 121. Taj Oncology Oncology Injection Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 122. Taj Oncology Oncology Injection Drug Product and Services
Table 123. Taj Oncology Oncology Injection Drug SWOT Analysis
Table 124. Taj Oncology Recent Developments
Table 125. S.G. Biopharm Company Information
Table 126. S.G. Biopharm Description and Overview
Table 127. S.G. Biopharm Oncology Injection Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 128. S.G. Biopharm Oncology Injection Drug Product and Services
Table 129. S.G. Biopharm Oncology Injection Drug SWOT Analysis
Table 130. S.G. Biopharm Recent Developments
Table 131. AdvaCare Company Information
Table 132. AdvaCare Description and Overview
Table 133. AdvaCare Oncology Injection Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 134. AdvaCare Oncology Injection Drug Product and Services
Table 135. AdvaCare Oncology Injection Drug SWOT Analysis
Table 136. AdvaCare Recent Developments
Table 137. Merrimack Company Information
Table 138. Merrimack Description and Overview
Table 139. Merrimack Oncology Injection Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 140. Merrimack Oncology Injection Drug Product and Services
Table 141. Merrimack Oncology Injection Drug SWOT Analysis
Table 142. Merrimack Recent Developments
Table 143. Celgene Company Information
Table 144. Celgene Description and Overview
Table 145. Celgene Oncology Injection Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 146. Celgene Oncology Injection Drug Product and Services
Table 147. Celgene Oncology Injection Drug SWOT Analysis
Table 148. Celgene Recent Developments
Table 149. Allos Therapeutics Company Information
Table 150. Allos Therapeutics Description and Overview
Table 151. Allos Therapeutics Oncology Injection Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 152. Allos Therapeutics Oncology Injection Drug Product and Services
Table 153. Allos Therapeutics Oncology Injection Drug SWOT Analysis
Table 154. Allos Therapeutics Recent Developments
Table 155. Ferring Pharmaceuticals Company Information
Table 156. Ferring Pharmaceuticals Description and Overview
Table 157. Ferring Pharmaceuticals Oncology Injection Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 158. Ferring Pharmaceuticals Oncology Injection Drug Product and Services
Table 159. Ferring Pharmaceuticals Oncology Injection Drug SWOT Analysis
Table 160. Ferring Pharmaceuticals Recent Developments
Table 161. Genzyme Company Information
Table 162. Genzyme Description and Overview
Table 163. Genzyme Oncology Injection Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 164. Genzyme Oncology Injection Drug Product and Services
Table 165. Genzyme Oncology Injection Drug SWOT Analysis
Table 166. Genzyme Recent Developments
Table 167. Eli Lilly Company Information
Table 168. Eli Lilly Description and Overview
Table 169. Eli Lilly Oncology Injection Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 170. Eli Lilly Oncology Injection Drug Product and Services
Table 171. Eli Lilly Oncology Injection Drug SWOT Analysis
Table 172. Eli Lilly Recent Developments
Table 173. Praecis Pharmaceuticals Company Information
Table 174. Praecis Pharmaceuticals Description and Overview
Table 175. Praecis Pharmaceuticals Oncology Injection Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 176. Praecis Pharmaceuticals Oncology Injection Drug Product and Services
Table 177. Praecis Pharmaceuticals Oncology Injection Drug SWOT Analysis
Table 178. Praecis Pharmaceuticals Recent Developments
Table 179. Millennium Pharmaceuticals Company Information
Table 180. Millennium Pharmaceuticals Description and Overview
Table 181. Millennium Pharmaceuticals Oncology Injection Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 182. Millennium Pharmaceuticals Oncology Injection Drug Product and Services
Table 183. Millennium Pharmaceuticals Recent Developments
Table 184. Debiopharm Company Information
Table 185. Debiopharm Description and Overview
Table 186. Debiopharm Oncology Injection Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 187. Debiopharm Oncology Injection Drug Product and Services
Table 188. Debiopharm Recent Developments
Table 189. Alza Company Information
Table 190. Alza Description and Overview
Table 191. Alza Oncology Injection Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 192. Alza Oncology Injection Drug Product and Services
Table 193. Alza Recent Developments
Table 194. CordenPharma Company Information
Table 195. CordenPharma Description and Overview
Table 196. CordenPharma Oncology Injection Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 197. CordenPharma Oncology Injection Drug Product and Services
Table 198. CordenPharma Recent Developments
Table 199. Pharmascience Company Information
Table 200. Pharmascience Description and Overview
Table 201. Pharmascience Oncology Injection Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 202. Pharmascience Oncology Injection Drug Product and Services
Table 203. Pharmascience Recent Developments
Table 204. Key Raw Materials Lists
Table 205. Raw Materials Key Suppliers Lists
Table 206. Oncology Injection Drug Distributors List
Table 207. Oncology Injection Drug Customers List
Table 208. Oncology Injection Drug Market Trends
Table 209. Oncology Injection Drug Market Drivers
Table 210. Oncology Injection Drug Market Challenges
Table 211. Oncology Injection Drug Market Restraints
Table 212. Research Programs/Design for This Report
Table 213. Key Data Information from Secondary Sources
Table 214. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncology Injection Drug Product Picture
Figure 2. Global Oncology Injection Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Oncology Injection Drug Market Share by Type in 2024 & 2034
Figure 4. Organs Product Picture
Figure 5. Central Nervous System Product Picture
Figure 6. Circulatory/Musculoskeletal System Product Picture
Figure 7. Other Product Picture
Figure 8. Global Oncology Injection Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 9. Global Oncology Injection Drug Market Share by Application in 2024 & 2034
Figure 10. Lymphoma
Figure 11. Myeloma
Figure 12. Prostate Cancer
Figure 13. Other
Figure 14. Oncology Injection Drug Report Years Considered
Figure 15. Global Oncology Injection Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global Oncology Injection Drug Revenue 2018-2034 (US$ Million)
Figure 17. Global Oncology Injection Drug Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 18. Global Oncology Injection Drug Sales Quantity 2018-2034 (K Pcs)
Figure 19. Global Oncology Injection Drug Sales Quantity Market Share by Region (2018-2023)
Figure 20. Global Oncology Injection Drug Sales Quantity Market Share by Region (2024-2034)
Figure 21. North America Oncology Injection Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 22. North America Oncology Injection Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Europe Oncology Injection Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 24. Europe Oncology Injection Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 25. China Oncology Injection Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 26. China Oncology Injection Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 27. APAC Oncology Injection Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 28. APAC Oncology Injection Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Oncology Injection Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 30. Middle East, Africa and Latin America Oncology Injection Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by Oncology Injection Drug Sales Quantity in 2024
Figure 32. The Top 10 and Top 5 Players Market Share by Oncology Injection Drug Revenue in 2024
Figure 33. Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 34. Global Oncology Injection Drug Sales Quantity Market Share by Type (2018-2034)
Figure 35. Global Oncology Injection Drug Revenue Market Share by Type (2018-2034)
Figure 36. Global Oncology Injection Drug Sales Quantity Market Share by Application (2018-2034)
Figure 37. Global Oncology Injection Drug Revenue Market Share by Application (2018-2034)
Figure 38. North America Oncology Injection Drug Revenue Market Share by Company in 2024
Figure 39. North America Oncology Injection Drug Sales Quantity Market Share by Company in 2024
Figure 40. North America Oncology Injection Drug Sales Quantity Market Share by Type (2018-2034)
Figure 41. North America Oncology Injection Drug Revenue Market Share by Type (2018-2034)
Figure 42. North America Oncology Injection Drug Sales Quantity Market Share by Application (2018-2034)
Figure 43. North America Oncology Injection Drug Revenue Market Share by Application (2018-2034)
Figure 44. North America Oncology Injection Drug Revenue Share by Country (2018-2034)
Figure 45. North America Oncology Injection Drug Sales Quantity Share by Country (2018-2034)
Figure 46. U.S. Oncology Injection Drug Revenue (2018-2034) & (US$ Million)
Figure 47. Canada Oncology Injection Drug Revenue (2018-2034) & (US$ Million)
Figure 48. Europe Oncology Injection Drug Sales Quantity Market Share by Company in 2024
Figure 49. Europe Oncology Injection Drug Revenue Market Share by Company in 2024
Figure 50. Europe Oncology Injection Drug Sales Quantity Market Share by Type (2018-2034)
Figure 51. Europe Oncology Injection Drug Revenue Market Share by Type (2018-2034)
Figure 52. Europe Oncology Injection Drug Sales Quantity Market Share by Application (2018-2034)
Figure 53. Europe Oncology Injection Drug Revenue Market Share by Application (2018-2034)
Figure 54. Europe Oncology Injection Drug Revenue Share by Country (2018-2034)
Figure 55. Europe Oncology Injection Drug Sales Quantity Share by Country (2018-2034)
Figure 56. Germany Oncology Injection Drug Revenue (2018-2034) & (US$ Million)
Figure 57. France Oncology Injection Drug Revenue (2018-2034) & (US$ Million)
Figure 58. U.K. Oncology Injection Drug Revenue (2018-2034) & (US$ Million)
Figure 59. Italy Oncology Injection Drug Revenue (2018-2034) & (US$ Million)
Figure 60. Russia Oncology Injection Drug Revenue (2018-2034) & (US$ Million)
Figure 61. China Oncology Injection Drug Sales Quantity Market Share by Company in 2024
Figure 62. China Oncology Injection Drug Revenue Market Share by Company in 2024
Figure 63. China Oncology Injection Drug Sales Quantity Market Share by Type (2018-2034)
Figure 64. China Oncology Injection Drug Revenue Market Share by Type (2018-2034)
Figure 65. China Oncology Injection Drug Sales Quantity Market Share by Application (2018-2034)
Figure 66. China Oncology Injection Drug Revenue Market Share by Application (2018-2034)
Figure 67. APAC Oncology Injection Drug Sales Quantity Market Share by Company in 2024
Figure 68. APAC Oncology Injection Drug Revenue Market Share by Company in 2024
Figure 69. APAC Oncology Injection Drug Sales Quantity Market Share by Type (2018-2034)
Figure 70. APAC Oncology Injection Drug Revenue Market Share by Type (2018-2034)
Figure 71. APAC Oncology Injection Drug Sales Quantity Market Share by Application (2018-2034)
Figure 72. APAC Oncology Injection Drug Revenue Market Share by Application (2018-2034)
Figure 73. APAC Oncology Injection Drug Revenue Share by Region (2018-2034)
Figure 74. APAC Oncology Injection Drug Sales Quantity Share by Region (2018-2034)
Figure 75. Japan Oncology Injection Drug Revenue (2018-2034) & (US$ Million)
Figure 76. South Korea Oncology Injection Drug Revenue (2018-2034) & (US$ Million)
Figure 77. China Taiwan Oncology Injection Drug Revenue (2018-2034) & (US$ Million)
Figure 78. Southeast Asia Oncology Injection Drug Revenue (2018-2034) & (US$ Million)
Figure 79. India Oncology Injection Drug Revenue (2018-2034) & (US$ Million)
Figure 80. Middle East, Africa and Latin America Oncology Injection Drug Sales Quantity Market Share by Company in 2024
Figure 81. Middle East, Africa and Latin America Oncology Injection Drug Revenue Market Share by Company in 2024
Figure 82. Middle East, Africa and Latin America Oncology Injection Drug Sales Quantity Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Oncology Injection Drug Revenue Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Oncology Injection Drug Sales Quantity Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Oncology Injection Drug Revenue Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Oncology Injection Drug Sales Quantity Share by Country (2018-2034)
Figure 87. Middle East, Africa and Latin America Oncology Injection Drug Revenue Share by Country (2018-2034)
Figure 88. Brazil Oncology Injection Drug Revenue (2018-2034) & (US$ Million)
Figure 89. Mexico Oncology Injection Drug Revenue (2018-2034) & (US$ Million)
Figure 90. Turkey Oncology Injection Drug Revenue (2018-2034) & (US$ Million)
Figure 91. Israel Oncology Injection Drug Revenue (2018-2034) & (US$ Million)
Figure 92. GCC Countries Oncology Injection Drug Revenue (2018-2034) & (US$ Million)
Figure 93. Oncology Injection Drug Value Chain
Figure 94. Oncology Injection Drug Production Process
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed